📰 Abt News
Page 133 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
July 5, 2023
Capital Investment Advisory Services LLC increased its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 4.0% in the 1st quarter, HoldingsChannel.com reports. The firm owned 14,110 shares of the healthcare product maker’s stock after acquiring an additional 545 shares during the period. Capital Investment Advisory Services LLC’s holdings in Abbott Laboratories were worth $1,429,000 […]
July 5, 2023
Arcblock (ABT) traded 18.3% higher against the U.S. dollar during the 1-day period ending at 17:00 PM E.T. on July 5th. Arcblock has a total market capitalization of $9.94 million and $713,729.87 worth of Arcblock was traded on exchanges in the last 24 hours. During the last seven days, Arcblock has traded 8.4% higher against […]
July 5, 2023
Trust Co. of Virginia VA lifted its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 1.4% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 120,319 shares of the healthcare product maker’s stock after purchasing an additional 1,664 shares during the quarter. Abbott […]
July 4, 2023
AustralianSuper Pty Ltd boosted its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 3.5% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,746,023 shares of the healthcare product maker’s stock after acquiring an additional 91,720 shares during the quarter. Abbott […]
July 4, 2023
Arcblock (ABT) traded down 9.8% against the US dollar during the 24 hour period ending at 14:00 PM ET on July 4th. One Arcblock token can now be purchased for approximately $0.0858 or 0.00000277 BTC on exchanges. Over the last seven days, Arcblock has traded 19.7% higher against the US dollar. Arcblock has a market […]
July 4, 2023
James Hambro & Partners grew its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 46.1% in the first quarter, according to its most recent filing with the SEC. The firm owned 3,215 shares of the healthcare product maker’s stock after acquiring an additional 1,015 shares during the quarter. James Hambro & Partners’ […]
July 4, 2023
Cottage Street Advisors LLC purchased a new position in shares of Abbott Laboratories (NYSE:ABT – Free Report) in the 1st quarter, Holdings Channel.com reports. The institutional investor purchased 3,100 shares of the healthcare product maker’s stock, valued at approximately $314,000. A number of other institutional investors and hedge funds have also bought and sold shares […]
July 4, 2023
Cardinal Strategic Wealth Guidance reduced its position in Abbott Laboratories (NYSE:ABT – Free Report) by 8.6% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 2,712 shares of the healthcare product maker’s stock after selling 254 shares during the period. Cardinal Strategic […]
July 4, 2023
Kovack Advisors Inc. boosted its position in Abbott Laboratories (NYSE:ABT – Free Report) by 16.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 8,657 shares of the healthcare product maker’s stock after buying an additional 1,253 shares during the […]
July 4, 2023
West Oak Capital LLC increased its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 1.8% in the first quarter, Holdings Channel reports. The institutional investor owned 24,040 shares of the healthcare product maker’s stock after acquiring an additional 417 shares during the period. Abbott Laboratories makes up about 1.2% of West Oak Capital LLC’s […]